Sun Life Financial Inc Akebia Therapeutics, Inc. Transaction History

Sun Life Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$3.16 - $6.73 $108,564 - $231,215	-34,356 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$3.55 - $5.4 $688 - $1,047	194 Added 0.57%	34,356 $135,000
Q2 2019 Aug 08, 2019	BUY	$4.1 - $8.05 $11,918 - $23,401	2,907 Added 9.3%	34,162 $165,000
Q1 2019 May 14, 2019	BUY	$5.41 - $8.73 $169,089 - $272,856	31,255 New	31,255 $256,000
Q3 2018 Nov 13, 2018	SELL	$7.44 - $10.65 $143,703 - $205,704	-19,315 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$9.15 - $11.34 $176,732 - $219,032	19,315 New	19,315 $193,000

120

54.9M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $430M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Sun Life Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Sun Life Financial Inc with notifications on news.